open access

Vol 9, No 4 (2020)
Letters to the Editor
Published online: 2020-05-22
Get Citation

Inconsistency amongst the diagnostic criteria based on Ewing’s tests for diagnosing cardiac autonomic neuropathy in diabetes mellitus: an under-rated issue

Pooja Bhati, M. Ejaz Hussain
DOI: 10.5603/DK.2020.0016
·
Clinical Diabetology 2020;9(4):269-270.

open access

Vol 9, No 4 (2020)
Letters to the Editor
Published online: 2020-05-22

Abstract

Not available

Abstract

Not available
Get Citation

Keywords

cardiovascular autonomic reflex tests, autonomic neuropathy, diabetes mellitus

About this article
Title

Inconsistency amongst the diagnostic criteria based on Ewing’s tests for diagnosing cardiac autonomic neuropathy in diabetes mellitus: an under-rated issue

Journal

Clinical Diabetology

Issue

Vol 9, No 4 (2020)

Pages

269-270

Published online

2020-05-22

DOI

10.5603/DK.2020.0016

Bibliographic record

Clinical Diabetology 2020;9(4):269-270.

Keywords

cardiovascular autonomic reflex tests
autonomic neuropathy
diabetes mellitus

Authors

Pooja Bhati
M. Ejaz Hussain

References (13)
  1. Balcıoğlu AS, Müderrisoğlu H. Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment. World J Diabetes. 2015; 6(1): 80–91.
  2. Serhiyenko VA, Serhiyenko AA. Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment. World J Diabetes. 2018; 9(1): 1–24.
  3. O'Brien IA, McFadden JP, Corrall RJ. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. Q J Med. 1991; 79(290): 495–502.
  4. Low PA, Benrud-Larson LM, Sletten DM, et al. Autonomic symptoms and diabetic neuropathy: a population-based study. Diabetes Care. 2004; 27(12): 2942–2947.
  5. Ewing DJ, Martyn CN, Young RJ, et al. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 1985; 8(5): 491–498.
  6. Pop-Busui R. Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care. 2010; 33(2): 434–441.
  7. Vinik AI, Maser RE, Mitchell BD, et al. Diabetic autonomic neuropathy. Diabetes Care. 2003; 26(5): 1553–1579.
  8. Witte DR, Tesfaye S, Chaturvedi N, et al. EURODIAB Prospective Complications Study Group. Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia. 2005; 48(1): 164–171.
  9. Spallone V, Bernardi L, Ricordi L, et al. Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy. Diabetes. 1993; 42(12): 1745–1752.
  10. Bellavere F, Bosello G, Fedele D, et al. Diagnosis and management of diabetic autonomic neuropathy. Br Med J (Clin Res Ed). 1983; 287(6384): 61.
  11. Spallone V, Ziegler D, Freeman R, et al. Toronto Consensus Panel on Diabetic Neuropathy. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011; 27(7): 639–653.
  12. Mendivil CO, Kattah W, Orduz A, et al. Neuropad for the detection of cardiovascular autonomic neuropathy in patients with type 2 diabetes. J Diabetes Complications. 2016; 30(1): 93–98.
  13. Kempler P, Tesfaye S, Chaturvedi N, et al. EURODIAB IDDM Complications Study Group. Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study. Diabet Med. 2002; 19(11): 900–909.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl